JP2016517409A5 - - Google Patents

Download PDF

Info

Publication number
JP2016517409A5
JP2016517409A5 JP2016500472A JP2016500472A JP2016517409A5 JP 2016517409 A5 JP2016517409 A5 JP 2016517409A5 JP 2016500472 A JP2016500472 A JP 2016500472A JP 2016500472 A JP2016500472 A JP 2016500472A JP 2016517409 A5 JP2016517409 A5 JP 2016517409A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
hydrogen
linear
hydroxymethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016500472A
Other languages
English (en)
Japanese (ja)
Other versions
JP6407951B2 (ja
JP2016517409A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/019126 external-priority patent/WO2014158654A1/en
Publication of JP2016517409A publication Critical patent/JP2016517409A/ja
Publication of JP2016517409A5 publication Critical patent/JP2016517409A5/ja
Application granted granted Critical
Publication of JP6407951B2 publication Critical patent/JP6407951B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016500472A 2013-03-14 2014-02-27 Ship1モジュレーターおよびそれに関連する組成物および方法 Expired - Fee Related JP6407951B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361786020P 2013-03-14 2013-03-14
US61/786,020 2013-03-14
PCT/US2014/019126 WO2014158654A1 (en) 2013-03-14 2014-02-27 Ship1 modulators and methods related thereto

Publications (3)

Publication Number Publication Date
JP2016517409A JP2016517409A (ja) 2016-06-16
JP2016517409A5 true JP2016517409A5 (enExample) 2017-02-09
JP6407951B2 JP6407951B2 (ja) 2018-10-17

Family

ID=50288307

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016500472A Expired - Fee Related JP6407951B2 (ja) 2013-03-14 2014-02-27 Ship1モジュレーターおよびそれに関連する組成物および方法

Country Status (14)

Country Link
US (2) US9765085B2 (enExample)
EP (1) EP2970122B1 (enExample)
JP (1) JP6407951B2 (enExample)
KR (3) KR20220110337A (enExample)
CN (2) CN108892637A (enExample)
AU (1) AU2014242041B2 (enExample)
BR (1) BR112015023009A2 (enExample)
CA (1) CA2902768A1 (enExample)
ES (1) ES2740779T3 (enExample)
IL (1) IL240968A0 (enExample)
MX (1) MX2015012111A (enExample)
RU (1) RU2679805C2 (enExample)
WO (1) WO2014158654A1 (enExample)
ZA (1) ZA201506674B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2015133177A (ru) 2013-01-09 2017-02-14 Экуинокс Фармасьютикалз (Кэнэда) Инк. Модуляторы ship1 и связанные с ними способы
US10100056B2 (en) 2013-03-14 2018-10-16 Aquinox Pharmaceuticals (Canada) Inc. SHIP1 modulators and methods related thereto
EP2970122B1 (en) 2013-03-14 2019-05-08 Aquinox Pharmaceuticals (Canada) Inc. Ship1 modulators
EP3313811A1 (en) * 2015-06-26 2018-05-02 Aquinox Pharmaceuticals (Canada) Inc. Crystalline solid forms of the acetate salt of (1s,3s,4r)-4-((3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
WO2017127753A1 (en) 2016-01-20 2017-07-27 Aquinox Pharmaceuticals (Canada) Inc. Synthesis of a substituted indene derivative
JP2019508424A (ja) * 2016-03-02 2019-03-28 パセオン オーストリア ゲーエムベーハー ウント ツェーオー カーゲー 17(20)−エン b−セコステロイドの生産のためのプロセスと中間体
WO2018126040A1 (en) 2016-12-28 2018-07-05 Aquinox Pharmaceuticals (Canada) Inc. Crystalline solid forms of (1s,3s,4r)-4-((3as,4r,5s,7as)-4- (aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3- (hydroxymethyl)-4-methylcyclohexanol
JP2021526545A (ja) * 2018-04-06 2021-10-07 アキノックス ファーマシューティカルス(カナダ)インク. 疼痛及び炎症を治療するのに有用なインデン誘導体
JP2021526546A (ja) * 2018-04-06 2021-10-07 アキノックス ファーマシューティカルス(カナダ)インク. 疼痛及び炎症を治療するのに有用なインデン誘導体
WO2019195692A1 (en) * 2018-04-06 2019-10-10 Aquinox Pharmaceuticals (Canada) Inc. Hexadecahydro-1h-cyclopenta[a]phenanthrene derivatives useful in treating pain and inflammation
CN112940062B (zh) * 2021-02-23 2022-09-06 浙江神洲药业有限公司 一种16-去氢黄体酮的制备方法
CN117024374A (zh) * 2023-08-08 2023-11-10 安庆百谊生物科技有限公司 一种3-甲基-1,2,4-噻二唑-5-碳酰肼或其盐的合成方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1084718B (de) 1958-07-08 1960-07-07 Bayer Ag Verfahren zur Herstellung von Secosteroiden
SE345995B (enExample) 1969-01-31 1972-06-19 Bristol Myers Co
US3682983A (en) 1969-11-12 1972-08-08 Klaus Prezewowsky Preparation of {66 {11 {11 -17 ethinyl steroids
US3869467A (en) 1972-06-05 1975-03-04 Hoffmann La Roche 17-{62 -Hydroxy-17-{60 -methyl-5-{60 -androstano{9 3,2-c{9 or{8 2,3-d{9 isoxazoles
US3962275A (en) 1972-06-05 1976-06-08 Hoffmann-La Roche Inc. 7-oxa steroids
JPH01290624A (ja) 1988-05-16 1989-11-22 Shiono Chem Kk 5,6―セコ―ステロール誘導体血清脂質低下剤
JPH07502511A (ja) 1991-12-20 1995-03-16 グラクソ、インコーポレーテッド 5‐α‐テストステロンレダクターゼ阻害剤
JPH05221924A (ja) 1992-02-17 1993-08-31 Shiono Chem Kk セコステロール化合物
JPH05221901A (ja) 1992-02-17 1993-08-31 Shiono Chem Kk セコステロール誘導体
US5464866A (en) 1992-08-17 1995-11-07 Alcon Laboratories, Inc. Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
AP459A (en) 1992-12-18 1996-02-14 Glaxo Wellcome Inc Substituted 6-azaandrostenones.
AU699200B2 (en) 1993-07-09 1998-11-26 Roger Bouillon Novel structural analogues of vitamin D
US5541322A (en) 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US6046185A (en) 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
EP1118654A4 (en) 1999-04-16 2007-03-07 Nippon Mitsubishi Oil Corp TRANSMISSION FLUID
SK15692002A3 (sk) 2000-04-28 2003-11-04 Inflazyme Pharmaceuticals Limited 3-Amino-6,7-dioxygénované steroidy a s nimi súvisiace použitie
US6696580B2 (en) 2001-05-22 2004-02-24 Inflazyme Pharmaceuticals Ltd. Process for the production of 6,7-diols of steroidal compounds
CA2463136A1 (en) 2001-10-17 2003-04-24 Raymond Andersen Ship 1 modulators
JP4753581B2 (ja) 2002-10-17 2011-08-24 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア Ship1モデュレーター
CN1805915A (zh) 2003-04-15 2006-07-19 茵弗莱采姆药物有限公司 作为药物活性剂的茚衍生物
WO2007147252A1 (en) 2006-06-21 2007-12-27 The University Of British Columbia Ship 1 modulator prodrugs
WO2008038965A1 (en) * 2006-09-26 2008-04-03 Kyungpook National University Industry-Academic Cooperation Foundation 7alpha-aminosteroid derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for anticancer or antibiotics containing the same as an active ingredient
US8101605B2 (en) * 2009-12-04 2012-01-24 Aquinox Pharmaceuticals Inc. SHIP1 modulators and methods related thereto
EP2605767B1 (en) 2010-08-20 2016-07-27 The University Of British Columbia Ship1 modulators and related methods
WO2012082750A1 (en) * 2010-12-13 2012-06-21 Rutgers University Methods of producing and using brassinosteroids to promote growth, repair and maintenance of skeletal muscle and skin
US10100056B2 (en) 2013-03-14 2018-10-16 Aquinox Pharmaceuticals (Canada) Inc. SHIP1 modulators and methods related thereto
EP2970122B1 (en) 2013-03-14 2019-05-08 Aquinox Pharmaceuticals (Canada) Inc. Ship1 modulators
EP3313811A1 (en) 2015-06-26 2018-05-02 Aquinox Pharmaceuticals (Canada) Inc. Crystalline solid forms of the acetate salt of (1s,3s,4r)-4-((3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
WO2017127753A1 (en) 2016-01-20 2017-07-27 Aquinox Pharmaceuticals (Canada) Inc. Synthesis of a substituted indene derivative
WO2018058144A1 (en) 2016-09-26 2018-03-29 Aquinox Pharmaceuticals (Canada) Inc. Ship1 activator for treating prostatis

Similar Documents

Publication Publication Date Title
JP7626722B2 (ja) アミノピリミジンアミドオートファジー阻害剤およびその使用方法
RU2015143676A (ru) Модулятолры ship1 и относящиеся к ним способы
JP7834721B2 (ja) 急速進行性線維肉腫タンパク質分解化合物及び関連する使用方法
US20220002313A1 (en) Hpk1 inhibitors and methods of using same
US10913727B2 (en) Modulators of the integrated stress pathway
JP5805763B2 (ja) C型肝炎ウイルス阻害剤
KR102534028B1 (ko) 트리아졸로피리미딘 화합물 및 그의 용도
RU2718917C2 (ru) Комбинированное лечение агонистом толл-подобного рецептора (tlr7) и ингибитором сборки капсида вируса гепатита в
SG11202111918PA (en) Substituted cycloalkyls as modulators of the integrated stress pathway
CN108434149B (zh) 针对Rb阳性异常细胞增殖的HSPC节制性治疗
JP6213564B2 (ja) キノリン誘導体
JP2020518561A (ja) Pd−1/pd−l1阻害剤
CN112312904A (zh) 螺环化合物
AU2018346597A1 (en) Inhibiting Ubiquitin Specific Peptidase 30
JP2020517667A (ja) 抗ウイルス剤としての融合インダゾールピリドン化合物
RU2018103944A (ru) Производные этинила как модуляторы метаботропного рецептора глутамата
AR079840A2 (es) Receptor nicotinico de acetilcolina, subtipo selectivo de amidas de diazabicicloalcanos
JP2018522034A5 (enExample)
TW201630891A (zh) 三環性螺化合物
AU2018240031A1 (en) Compounds and methods for the treatment of parasitic diseases
US20220064123A1 (en) (--)-Huperzine A Processes and Related Compositions and Methods of Treatment
EA036318B1 (ru) 6-аминопиридин-3-илтиазолы в качестве модуляторов rort
AU2019286531A1 (en) Pyrazole and imidazole compounds for inhibition of IL-17 and rorgamma
JPWO2006137527A1 (ja) チアゾール誘導体
JP2017516772A5 (enExample)